Expertise in
1
conditions

Giovanni Marotta

North York, ON, CA 
Expertise in
1
conditions
North York, ON, CA 

Overview

Giovanni Marotta practices practicing medicine in North York, Canada.

Mr. Marotta is highly rated in 1 condition, according to our data. His clinical expertise encompasses Dementia, Drug Induced Dyskinesia, Movement Disorders, and Parkinson's Disease.

He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

North York, ON, Canada
Other Locations
Toronto, ON, Canada
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The SARTAN-AD Trial: A Randomized, Open Label, Proof of Concept Study of Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
The SARTAN-AD Trial: A Randomized, Open Label, Proof of Concept Study of Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
Enrollment Status: Terminated
Publish Date: May 06, 2025
Intervention Type: Drug
Study Drugs: Perindopril, Telmisartan
Study Phase: Phase 2
Escitalopram for Agitation in Alzheimer's Disease
Escitalopram for Agitation in Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drug: Escitalopram
Study Phase: Phase 3
A 6-Month, Double-Blind, Phase 2 Study and 6-Month Open- Label Extension Evaluating the Safety, Tolerability, and Clinical Benefit of RPh201 in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease
A 6-Month, Double-Blind, Phase 2 Study and 6-Month Open- Label Extension Evaluating the Safety, Tolerability, and Clinical Benefit of RPh201 in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease
Enrollment Status: Completed
Publish Date: April 30, 2020
Intervention Type: Drug, Other
Study Phase: Phase 2
View 2 Less Clinical Trials

8 Total Publications

Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis.
Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis.
Journal: CNS drugs
Published: October 18, 2025

Frequently Asked Questions about Giovanni Marotta

Is Giovanni Marotta a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Giovanni Marotta is classified as an Advanced expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Giovanni Marotta participate in research or clinical trials?

Yes. Giovanni Marotta has published 8 articles and abstracts on conditions like Dementia. You can view a list of Giovanni Marotta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Marotta's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile